Response to: Comment on “Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real‐World Study”
The Journal of Dermatology · 2026-11 · 53 (11)
DOI: 10.1111/1346-8138.70481 ↗Kurz gefasst
Leserbrief in der Zeitschrift The Journal of Dermatology, online erschienen am 25.08.2026. Verfasst von Kuo-Tung Tang. Beteiligte Einrichtung: Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Taichung Veterans General Hospital, National Health Research Institutes.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan.
- School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Ph.D. Program in Translational Medicine, National Chung Hsing University, Taichung, Taiwan.
ORCID-Profile: Kuo-Tung Tang
Förderung
- Taichung Veterans General Hospital
- National Health Research Institutes
Zitieren
APA
Tang, K. T. (2026). Response to: Comment on “Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real‐World Study”. The Journal of Dermatology, 53(11). https://doi.org/10.1111/1346-8138.70481
Vancouver
Tang KT. Response to: Comment on “Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real‐World Study”. The Journal of Dermatology. 2026;53(11). doi:10.1111/1346-8138.70481
BibTeX
@article{Tang2026,
author = {Tang, Kuo-Tung},
title = {Response to: Comment on “Achieving Targeted Combined Endpoints in Patients With Atopic Dermatitis: A Real‐World Study”},
journal = {The Journal of Dermatology},
year = {2026},
volume = {53},
number = {11},
doi = {10.1111/1346-8138.70481}
}
EUVIMED